Clinical Trial Update: ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer [NA]

View source ↗

Summary

This entry describes an ongoing clinical trial evaluating circulating tumor DNA testing to guide standard-of-care treatment decisions for endometrial cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Endometrial Cancer | NA | Status: RECRUITING